Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trop2-targeting the Second Near-Infrared Fluorescence(NIR-II ) Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer

NCT06972771 is registered in ClinicalTrials.gov with Yunnan Cancer Hospital as lead sponsor.

NCT NCT06972771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06972771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trop2-targeting the Second Near-Infrared Fluorescence(NIR-II ) Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer
Lead sponsor
Yunnan Cancer Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 17, 2025
Completion date
January 30, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer (bc)